Sunnyvale, California-based Intuitive Surgical, Inc. (ISRG) develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. Valued at a market cap of $145.6 billion, the company offers the da Vinci Surgical System, which enables minimally invasive surgical procedures, the Ion endoluminal system, and more.
ISRG is expected to release its Q3 2026 earnings after the market closes on Tuesday, October 20. Ahead of this event, analysts anticipate the company will generate earnings of $2.13 per share, representing an increase of 8.7% from $1.96 per share reported in the same quarter last year. The company has surpassed the Street’s bottom-line estimates in each of the past four quarters, which is impressive.